By reason of the imminent launch of Ximluci® in Europe, Xbrane Biopharma AB invites to a Capital Markets Day on September 22, 2022

Stockholm, Sweden – Xbrane Biopharma AB (publ) (Nasdaq Stockholm: XBRANE), invites analysts, investors and the media to its Capital Markets Day on September 22, 2022 by reason of EMA's positive opinion for ranibizumab biosimilar candidate Ximluci® (Xlucane®) and the now imminent launch in Europe.

The Capital Markets Day will be held in the Nils Ringertz hall, Biomedicum, floor 3, Solnavägen 9, Solna, starting at 2 pm and will also be broadcast digitally. Refreshments are served from 1.30 pm.

Please register your personal participation at: IR@xbrane.com and digital participation by following the link: https://tv.streamfabriken.com/xbrane-biopharma-cmd-2022.

Datum 2022-09-19, kl 13:00
Källa MFN
Hej Serverägare! Har du problem med troll och spam? Nu finns möjligheten att sätta en liten avgift, t.ex. 20kr, på discord invites och därmed stoppa många återkommande troll samtidigt som du tjänar lite pengar. Kolla in Invite Paywall.